ADDRESSING THE 5MS OF OSTEOPOROSIS MANAGEMENT

Sponsored by the Osteoporosis and Metabolic Bone Disease Special Interest Group 
Moderator: Cathleen S. Colón-Emeric, MD, MHS 
In light of the new clinical practice guidelines from the Bone Health and Osteoporosis Foundation and advances in pharmacotherapy, this program will support attendees in providing evidence-based fracture prevention for patients with osteoporosis. Learning Objectives: (1) describe mobility interventions and care models that improve bone health and reduce injurious falls in older adults; (2) appropriately prescribe osteoporosis treatment regimens in common clinical scenarios, based on their pharmacobiology, risks, and benefits; (3) describe the pitfalls of race-based decisions in selecting osteoporosis pharmacotherapy; (4) tailor osteoporosis treatment plans for patients with multimorbidity, including dementia and chronic kidney disease; and (5) list elements of, and tools promoting, shared decision making around fracture prevention options with older adults and their care partners.